Drug-resistant tuberculosis viewed from bacterial and host genomes

Area of Science:

• Microbiology
• Genetics
• Immunology

Background:

• Tuberculosis (TB) infection outcomes are significantly shaped by host-pathogen interactions.
• Both the human host and Mycobacterium tuberculosis (MTB) genetic backgrounds are critical determinants in TB.
• The role of these interactions in the selection and spread of drug-resistant MTB strains requires further investigation.

Purpose of the Study:

• To review the influence of host-pathogen interactions on the development of drug-resistant MTB strains.
• To summarize MTB genetic determinants associated with drug resistance.
• To examine human genetic factors implicated in TB drug resistance.

Main Methods:

• Literature review of recent findings on MTB determinants of drug resistance.
• Analysis of studies investigating human genetic factors in TB drug resistance.
• Synthesis of current knowledge on host-pathogen genetics in TB.

Main Results:

• MTB possesses specific genetic determinants that contribute to the emergence of drug resistance.
• Human genetic variations can influence an individual's susceptibility and response to TB, potentially affecting drug resistance.
• The interplay between host and pathogen genetics is a key factor in TB pathogenesis and drug resistance.

Conclusions:

• Host-pathogen genetic interactions are pivotal in shaping the outcome of MTB infections, including the development of drug resistance.
• Understanding these genetic underpinnings offers new opportunities for TB research and the development of novel therapeutic strategies.
• Further research into the genetic landscape of both humans and MTB is essential for combating drug-resistant TB.